RGBP earnings: a positive outcome, +5.7%

On April 24, 2024, Regen BioPharma Inc reached its earnings. The result was a positive outcome, and the stock moved +5.7% in the window around the event. It had already run -5.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.